Latest Seizure types Stories

2009-03-23 08:57:00

WASHINGTON, March 23 /PRNewswire-USNewswire/ -- Kiley Carlson of Sioux City, IA will travel to Washington, D.C., Sunday, March 29 through Tuesday, March 31, 2009 to meet with congressional leaders and gain their support for epilepsy public health programs and more research toward a cure for epilepsy. Carlson, 16, is one of 37 young people from across the country participating in Kids Speak Up!, a national program coordinated by the Epilepsy Foundation and funded by Abbott Laboratories. The...

2009-02-19 09:02:00

LONDON, February 19 /PRNewswire-FirstCall/ -- - Eisai Set to Become an Emerging Leader in the Treatment of Epilepsy Eisai Europe Ltd (London; Chairman & CEO Yutaka Tsuchiya), the European subsidiary of Eisai Co., Ltd. (Tokyo, President & CEO: Haruo Naito), and Bial-Portela & CA, S.A., (S. Mamede do Coronado, Portugal, CEO Dr Luis Portela) today announced the signing of a licence and co-promotion agreement in which Eisai receives a sole license to market, promote and...

2008-12-01 08:24:00

Since 2005, UCB has awarded over half a million dollars to qualified recipients ATLANTA, Dec. 1 /PRNewswire/ -- UCB, The Epilepsy Company(TM), will honor 31 recipients of the 2008 UCB Family Epilepsy Scholarship(TM) at a reception in Seattle, WA on Sunday, December 7 during the American Epilepsy Society Annual Meeting. The scholarship is awarded to inspiring people whose lives have been affected by epilepsy, and who seek personal growth through higher learning. Each year, the UCB Family...

2008-09-25 12:00:43

Bial, a Portuguese pharmaceutical company, has reported positive data from three Phase III studies which showed that Zebinix, a once daily anti-epileptic agent, has significantly reduced the frequency of partial seizures in patients with refractory partial epilepsy, in combination with other anti-epileptic agents. In addition, treatment with Zebinix also significantly improved patient quality of life, reduced depressive symptoms and demonstrated sustained reduction in partial seizure...

2008-07-25 09:01:18

Ortho-McNeil Neurologics, a division of Ortho-McNeil-Janssen Pharmaceuticals, has announced that the FDA has granted pediatric exclusivity for Topomax. The grant was based on studies submitted in response to a written request by the FDA to investigate the use of Topomax in pediatric patients aged one to 24 months with partial onset seizures. In addition to granting pediatric exclusivity, the FDA is continuing its review of the application to determine the safety and efficacy of Topomax in...

2008-05-08 00:50:00

On Easter weekend, a hacker who didn't intend to steal visitors' personal information hit the Epilepsy Foundation's Web site. Instead the hacker posted rapidly flashing images on the foundation's Web site, causing many migraines and near-seizure reactions."This was clearly an act of vandalism with the intent to harm people, and we shut the attack down immediately," said Eric R. Hargis, president and CEO of the Epilepsy Foundation. "We've established deterrents in the system to prevent similar...

2008-01-18 17:30:00

Stacey Gayle's seizures are now a thing of the past, thanks in large part to her favorite musician Sean Paul.Gayle, a 25-year-old Canadian woman diagnosed with a rare condition known as musicogenic epilepsy, for years suffered from as many as 10 grand mal seizures a day, despite treatments to control them. Then eighteen months ago she made a discovery that changed the course of her life. She began to suspect that the music she was listening to might be causing her seizures. In...

2005-09-12 17:06:20

ST. PAUL, Minn. "“ Using a blood test to measure the level of the hormone prolactin can help determine, in certain clinical settings, whether an epileptic seizure has occurred, according to a guideline developed by the American Academy of Neurology and published in the September 13, 2005 issue of Neurology. The guideline authors reviewed all of the scientific evidence available on use of the prolactin blood test to diagnose seizures and developed evidence-based recommendations. The...

2005-07-01 16:20:00

WINSTON-SALEM, N.C. "“ New research suggests novel treatment targets for the most common form of childhood epilepsy "“ with the potential to have fewer side effects than traditional therapy. The findings from Wake Forest University School of Medicine are reported today in the July issue of the Journal of Neurophysiology. Through studies in animals, the researchers learned more about the possible brain pathways involved in absence, or petit mal, seizures and tested a drug that...

Word of the Day
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.